Hagens berman, national trial attorneys, encourages athira pharma (atha) investors to contact firm's attorneys now, firm investigating possible securities law violations

San francisco, california--(newsfile corp. - june 22, 2021) -  hagens berman urges athira pharma, inc. (nasdaq: atha) investors with significant losses to submit your losses now. the firm is investigating possible securities law violations related to athira's recent decision to place its ceo (leen kawas) on temporary leave. visit: www.hbsslaw.com/investor-fraud/atha contact an attorney now: atha@hbsslaw.com 844-916-0895athira pharma, inc. (atha) investigation:the investigation focuses on matters prompting athira's...
ATHA Ratings Summary
ATHA Quant Ranking